Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment-Reference-Cited by-同舟云学术

Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment

Published:2012 Issue:12 Volume:18 Page:CR721-CR728
ISSN:1234-1010
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Jaeger Bernadette Anna Sophia¹,Tauer Josephine Tabea¹,Ulmer Anna¹,Kuhlisch Eberhard²,Roth Heinz Juergen³,Suttorp Meinolf¹

Affiliation:

1. Department of Pediatrics, University Hospital “Carl Gustav Carus”, Technical University, Dresden, Germany

2. Institute of Medical Informatics and Biometry, University Hospital “Carl Gustav Carus”, Technical University, Dresden, Germany E-mail: Eberhard.Kuhlisch@tu-dresden.de

3. Department of Endocrinology/Oncology, Limbach Laboratory, Heidelberg, Germany

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials;Frontiers in Oncology;2023-12-20

2. Effect of Imatinib Mesylate on Growth in Pediatric Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis;Journal of Pediatric Hematology/Oncology;2023-03-17

3. Evaluation of Bone Turnover Markers in Patients with Acute and Chronic Leukemia;Indian Journal of Clinical Biochemistry;2023-03-03

4. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022;Bone Marrow Transplantation;2022-05-19

5. Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters;Current Therapeutic Research;2022